CTO, GenFleet Therapeutics
Dr.Jingrong Li obtained his Bachelor degree and PhD degree from China Pharmaceutical University. He went to Mount Sinai School of Medicine afterwards for his postdoctoral training in biochemistry and later worked as the instructor at Mount Sinai Medical Center. He has over two decades of work experience in biologics industries targeting on R&D and commercial manufacturing. Especially in biopharmaceutical process development, control method development, process scale up, large-scale production and core technology of upstream and downstream. He is now the Chief Technology Officer of GenFleet Therapeutics.